Home
About
Overview
Sharing Data
ORCID
Help
History (28)
HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/?c(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
Jeff Zucker Says Hypertrophic Cardiomyopathy is a Curable Disease: A Patient's Perspective.
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.
Health Benefit Plans, Employee
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?
See All 28 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?
Semsarian C, Ingles J, Maron MS, Maron BJ. Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy? J Am Coll Cardiol. 2015 Oct 20; 66(16):1846-1847.
View in:
PubMed
subject areas
Cardiomyopathy, Hypertrophic
Death, Sudden, Cardiac
Female
Genetic Predisposition to Disease
Humans
Male
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD